Navigation Links
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Date:11/5/2009

hapes in both men and women. Each year in the United States alone, there are over 750,000 new cases of ano-genital warts. Treatment options today are limited by tolerability issues such as pain, irritation and swelling at the treatment site. Treatments may include topical preparations, intralesional injection of interferon Alpha-2b and surgically ablative procedures. Helix believes that more effective and better tolerated treatments are needed.

About Topical Interferon Alpha-2b

Interferon Alpha-2b is an immune system modulator that is active against a variety of HPV-induced lesions. Interferon Alpha-2b is thought to function by triggering an antiviral response within infected cells, by activating certain intracellular enzymes which cause degradation of viral RNA, and by mobilizing the body's natural immune system to destroy the infected cells. Interferon Alpha-2b has been widely used commercially as a treatment for ano-genital warts caused by HPV, but is not generally favored due to the fact that conventional administration requires painful intralesional injection by a medical professional. Furthermore, intralesional injection is restricted to visible lesion administration, while HPV infection is often characterized by both visible and non-visible (i.e. sub-clinical) lesions. Helix's Topical Interferon Alpha-2b utilizes the Company's proprietary Biphasix(TM) drug delivery technology, and is expected to offer a safe, discreet, self-administered, pain-free therapy that can be broadly applied across the entire affected tissue area. Helix anticipates that this will prove highly advantageous not only from a patient compliance perspective by offering a superior tolerability profile, but also from an efficacy standpoint.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prev
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal 2009 Results
2. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
3. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
4. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
6. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
11. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... 2014  4WEB Medical announces the formal launch of ... osteotomy implants on the market today at this ... in Chicago .  The Osteotomy Truss ... needs with 74 size options included in one versatile ... only 15 to 18 implant sizes, which limited a ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
... Cellceutix Corporation (Pink Sheets: CTIX ) today ... Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with ... Cellceutix CEO, Leo Ehrlich, commented, "It,s relatively uncommon ... a compound before clinical trials are underway.  The process ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Barclay,s 2011 Global Healthcare Conference ... presentation will be webcast live and can be accessed ...
Cached Medicine Technology:Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 2Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 3
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... 2014 Recently, Best Cheap Hosting ... launched its new website. The new site provides ... hosting products for customers. Here, people can find ... purchasing decision. Also, it has recommended some excellent ... One of the great web hosting suppliers, InMotion ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking coffee ... is re-visiting that advice and changing his stance after considering ... have on oral health. “There’s good news and great news,” ... beneficial in protecting against gum disease, and red wine can ... was from the September 2014 issue of Boston University ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Recently, UWDress.com, ... dresses and women’s special occasion outfits, has launched a ... The company’s prom outfits are popular among worldwide clients. ... get wholesale prom dresses on its website. ... for customers from around the world. Great custom made ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... million of their customers may have had their credit card ... late last year, spawning a slew of headline articles ... but those weren’t the only eye opening numbers. , ... numbers were stolen, almost like it’s a way to score ...
Breaking Medicine News(10 mins):Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5
... Healthcare Leaders With Information and,Best Practices Related ... WASHINGTON, April 17 The new ... that will eliminate or,reduce payments for three ... a two-day conference for healthcare executives and ...
... Projects show potential of computer science to profoundly impact prediction ... and treatment ... with the ability to predict and prevent adverse drug responses,within ... illnesses such as Parkinson,s disease and Alzheimer,s,disease, are just two ...
... In a move that will benefit children of ... premier childrens hospitals in the United States, and the ... have formalized a longtime relationship by officially becoming international ... sister cities, the formal linkage of hospitals in two ...
... Trust Inc.,(NYSE: CRE ) today announced it named ... Care,s Board of Directors, which increases the,number of members ... as President of Corporate Finance at CIT, Owens, 48, ... leaders,in assessing their go-to-market models, developing integrated distribution,platforms that ...
... 2008 Babies with an eye-alignment disorder called ... but development catches up after corrective surgery, reports ... (American Association for Pediatric Ophthalmology and Strabismus). , ... Retina Foundation of Southwest Texas, Dallas, the researchers ...
... Technology through ... ... Medical,Solutions USA Inc. (http://www.siemens.com/healthcare ) today announced a ... in numerous,strategic healthcare industry organizations., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
Cached Medicine News:Health News:APIC Conference to Address New CMS Regulations 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 3Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 4Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 5Health News:Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals 2Health News:Care Investment Trust Names Walter J. Owens to Board of Directors 2Health News:Infantile esotropia linked to developmental delays 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 3Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 4Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 5
ELISA kit for Varicella-zoster IgM....
... (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is ... of IgG antibody to VZV in human ... used for the determination of immune status. ... used to demonstrate seroconversion or a significant ...
... The Zeus Scientific, Inc. Mumps IgG ELISA ... detection of Mumps IgG antibody in human ... the results of this test, together with ... determination of immune status, and/or aid in ...
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
Medicine Products: